Nerve Growth Factor

DB12620InvestigationalProtein Based Therapies

Nerve Growth Factor has been used in trials studying the prevention and treatment of Mental Handicap, Alzheimer's Disease, Traumatic Brain Injury, Cerebral Palsy Children, and Delayed Speech Development, among others.

Mechanism: Pharmacologically active on High affinity nerve growth factor receptor and Tumor necrosis factor receptor superfamily member 16
Curator reviewed
Also known as: rhNGF

Resolves to

Compound

UNIIV7FWP1D62OCAS9061-61-4

Clinical / RWD

RxNorm7327

Targets

P04629NTRK1P08138NGFR

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

25Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nerve Growth Factor, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account